SCHEMBL7954875

SCHEMBL7954875

O=C1N(Cc2ccccc2)CCCC1(CCO)Cc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.59
MEN1 O00255 1/20 0.59
L3MBTL1 Q9Y468 1/20 0.43
HCRTR1 O43613 4/20 0.42
HCRTR2 O43614 4/20 0.42
RIPK1 Q13546 1/20 0.41
DDB1 Q16531 1/20 0.40
CRBN Q96SW2 1/20 0.40
POLB P06746 2/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
ALDH1A1 P00352 1/20 0.37
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6999822 0.92 KMT2A (0.51) KMT2AMEN1L3MBTL1HCRTR1HCRTR2
SCHEMBL6733910 0.84 KMT2A (0.62) KMT2AMEN1L3MBTL1HCRTR1HCRTR2
SCHEMBL7954267 0.83 KMT2A (0.54) KMT2AMEN1L3MBTL1HCRTR1HCRTR2
SCHEMBL27378900 0.80 KMT2A (0.50) KMT2AMEN1L3MBTL1HCRTR1HCRTR2
SCHEMBL19585933 0.80 KMT2A (0.57) KMT2AMEN1L3MBTL1HCRTR1HCRTR2
SCHEMBL7046375 0.79 KMT2A (0.68) KMT2AMEN1L3MBTL1HCRTR1HCRTR2
SCHEMBL7947397 0.77 MEN1 (0.48) KMT2AMEN1L3MBTL1HCRTR1HCRTR2
SCHEMBL6999204 0.77 MAPK1 (0.46) KMT2AMEN1HCRTR1POLBCYP2C9
SCHEMBL9726979 0.75 KMT2A (1.00) KMT2AMEN1L3MBTL1HCRTR1HCRTR2
SCHEMBL6733707 0.75 KMT2A (0.54) KMT2AMEN1L3MBTL1HCRTR1HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6329392-B1 ANTIALLERGENS AVENTIS PHARMACEUTICALS, INC. 2001-12-11 US disclosed
CN-1067385-C Novel substituted piperidines useful for the treatment of allergic diseases MERRELL DOW PHARMA (US) 2001-06-20 CN disclosed
EP-0777666-B1 SUBSTITUTED PIPERIDINES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES MERRELL PHARMA INC (US) 1999-03-03 EP disclosed
CN-1158612-A Novel substituted piperidines for the treatment of allergic diseases MERRELL DOW PHARMA (US) 1997-09-03 CN disclosed
EP-0777666-A1 NOVEL SUBSTITUTED PIPERIDINES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES MERRELL PHARMACEUTICALS INC. (US) 1997-06-11 EP disclosed
WO-1996006094-A1 NOVEL SUBSTITUTED PIPERIDINES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES MERRELL PHARMACEUTICALS INC. (US) 1996-02-29 WO disclosed